Société Viracta Therapeutics, Inc. Nasdaq
Actions
US92765F1084
Recherche biotechnologique et médicale
Métier
Nombre d'employés: 40
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Mark Rothera
CEO | Chief Executive Officer | 62 | 19/09/22 |
Melody Burcar
DFI | Director of Finance/CFO | 41 | 01/09/22 |
Chief Tech/Sci/R&D Officer | - | - | |
Darrel Cohen
CTO | Chief Tech/Sci/R&D Officer | 59 | 07/08/23 |
Ayman El-Guindy
CTO | Chief Tech/Sci/R&D Officer | - | 06/07/21 |
Ivor Royston
BRD | Director/Board Member | 79 | 01/10/07 |
Ashleigh Barreto
IRC | Investor Relations Contact | - | 01/10/21 |
Corporate Officer/Principal | - | 06/07/21 | |
Patric Nelson
PRN | Corporate Officer/Principal | - | 06/07/21 |
Cheryl A. Madsen
LAW | General Counsel | - | - |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Ivor Royston
BRD | Director/Board Member | 79 | 01/10/07 |
Thomas Darcy
BRD | Director/Board Member | 74 | 01/02/21 |
Barry Simon
BRD | Director/Board Member | 69 | 03/03/21 |
Mark Rothera
CEO | Chief Executive Officer | 62 | 19/09/22 |
Roger Pomerantz
CHM | Chairman | 67 | 01/06/20 |
Flavia Borellini
BRD | Director/Board Member | 65 | 14/08/21 |
Jane Barlow
BRD | Director/Board Member | 63 | 14/08/21 |
Stephen Rubino
BRD | Director/Board Member | 65 | 03/03/21 |
Sam Murphy
BRD | Director/Board Member | - | 01/01/19 |
Jane Chung
BRD | Director/Board Member | 53 | 10/08/22 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 39 272 434 | 38 136 283 ( 97,11 %) | 0 | 97,08 % |
Action B | 0 | 10 248 | 0 | 0 |
Coordonnées société
Viracta Therapeutics, Inc.
2533 South Coast Highway 101 Suite 210
92007, Cardiff
+
http://www.viracta.comSecteur
Varia. 1 janv. | Capi. | |
---|---|---|
+1,77 % | 42,75 Md | |
+47,70 % | 41,61 Md | |
+12,24 % | 41,34 Md | |
-8,83 % | 26,59 Md | |
+7,44 % | 25,49 Md | |
-23,01 % | 18,12 Md | |
+30,56 % | 12,24 Md | |
-1,82 % | 11,76 Md | |
+8,35 % | 11 Md |